CCCC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $2.95

Piyasa Değeri (MRQ) $363M

P/E (TTM) -3.2

Hisse Başına Kâr (TTM) $-0.91

Gelir (TTM) $35M

ROE (TTM) -48.1%

52 Haftlık Aralık $2–$5

CCCC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

C4 Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Wikidata ↗

sektörHealthcare endüstriBiotechnology çalışanlar104 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$36M

2021-12-31 → 2025-12-31

Hisse Başına Kâr$-1.27

2021-12-31 → 2025-12-31

Serbest Nakit Akışı$-99M

2020-12-31 → 2025-12-31

Net kar marjı-289.4%

2022-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	CCCC	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-3.25Y ort. ≈-5.2	≈-5.2	·	·
F/S (TTM)	10.35Y ort. ≈14.5	≈14.5	16.4	Adil değer
F/D (MRQ)	1.55Y ort. ≈1.7	≈1.7	2.6	Adil değer
Fiyat / Serbest Nakit Akışı (TTM)	-4.25Y ort. ≈-5.9	≈-5.9	·	·
Fiyat / Nakit Akışı (TTM)	-4.35Y ort. ≈-5.9	≈-5.9	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	1.15Y ort. ≈1.7	≈1.7	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	CCCC	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-319.0%5Y ort. ≈-435.8%	≈-435.8%	-164.6%	Zayıf
EBITDA Margin (FAVÖK Marjı)	-320.5%5Y ort. ≈-435.8%	≈-435.8%	-164.6%	Zayıf
Pretax Margin (Vergi Öncesi Kar Marjı)	-291.7%5Y ort. ≈-406.5%	≈-406.5%	-135.6%	Zayıf
Net Kâr Marjı (TTM)	-289.4%5Y ort. ≈-409.6%	≈-409.6%	-245.9%	Ortalamanın altında
ROA (TTM)	-30.9%5Y ort. ≈-27.5%	≈-27.5%	-27.3%	Aynı seviyede
ROE (TTM)	-48.1%5Y ort. ≈-43.1%	≈-43.1%	-21.3%	Ortalamanın altında
ROIC	-45.0%5Y ort. ≈-52.5%	≈-52.5%	-45.8%	Aynı seviyede

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	CCCC	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		5.45Y ort. ≈6.5	≈6.5	5.4	Aynı seviyede
Quick Ratio (Cari Oran)		2.35Y ort. ≈2.7	≈2.7	2.7	Düşük likidite

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	5 Yıllık trend	CCCC	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)		1.0%5Y ort. ≈1.8%	≈1.8%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)		5.0%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	CCCC	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-1.275Y ort. ≈$-1.98	≈$-1.98	·	·
Revenue / Share (Hisse Başına Gelir)	$0.435Y ort. ≈$0.50	≈$0.50	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-1.195Y ort. ≈$-1.61	≈$-1.61	·	·
Cash / Share (Hisse Başına Nakit)	$0.775Y ort. ≈$1.16	≈$1.16	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	CCCC	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	0.15Y ort. ≈0.1	≈0.1	0.2	Zayıf
Receivables Turnover (Alacak Devir Hızı)	13.15Y ort. ≈7.4	≈7.4	7.9	En üst düzey
Revenue / Employee (Çalışan Başına Gelir)	≈$345.6K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 21.7%

Sonraki Rapor Kas 04, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 5, 2026	$-0.18	$-0.23	22.0%
31 Mart 2026		$-0.20	$-0.38	47.3%
31 Aralık 2025		$-0.18	$-0.31	41.9%
30 Eylül 2025		$-0.44	$-0.41	-6.2%
30 Haziran 2025		$-0.37	$-0.39	5.5%
31 Mart 2025		$-0.37	$-0.46	19.4%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 14

Metrik	2025	2024	2023	2022	2021
Revenue	$36M	$36M	$21M	$31M	$46M
R&D Expense	$104M	$111M	$118M	$118M	$95M
SG&A Expense	$36M	$42M	$42M	$43M	$33M
Operating Expenses	$151M	$155M	$160M	$161M	$128M
Operating Income	$-115M	$-120M	$-139M	$-130M	$-82M
Other Non-op	$10M	$14M	$8M	$1M	$-2M
Pretax Income	$-105M	$-105M	$-131M	$-128M	$-84M
Income Tax	$121.0K	$131.0K	$1M	$0	$0
Net Income	$-105M	$-105M	$-132M	$-128M	$-84M
EPS (Basic)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82
EPS (Diluted)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82
Shares (Basic)	82,894,459	69,372,993	49,640,505	48,861,665	46,041,733
Shares (Diluted)	82,894,459	69,372,993	49,640,505	48,861,665	46,041,733
EBITDA	$-115M	$-120M	$-139M	$-130M	$-82M

Bilanço 22

Metrik	2025	2024	2023	2022	2021
Cash & Equivalents	$75M	$55M	$127M	$30M	$76M
Short-term Investments	·	·	·	·	$233M
Receivables	$2M	$3M	$12M	$1M	$6M
Prepaid Expense	$7M	$10M	$6M	$10M	$11M
Current Assets	$258M	$258M	$271M	$288M	$326M
PP&E (Net)	$5M	$6M	$7M	$7M	$3M
PP&E (Gross)	$16M	$15M	$15M	$16M	$10M
Accum. Depreciation	$11M	$9M	$8M	$8M	$7M
Other Non-current Assets	$4M	$3M	$3M	$2M	$544.0K
Total Assets	$359M	$350M	$376M	$431M	$507M
Accounts Payable	$858.0K	$1M	$1M	$1M	$5M
Current Liabilities	$33M	$45M	$43M	$45M	$51M
Capital Leases	$54M	$60M	$66M	$71M	$31M
Total Liabilities	$102M	$134M	$130M	$142M	$117M
Long-term Debt	·	·	$0	$11M	$11M
Total Debt	·	·	$0	$11M	$11M
Common Stock	$9.0K	$7.0K	$6.0K	$5.0K	$5.0K
Retained Earnings	$-739M	$-634M	$-528M	$-396M	$-268M
AOCI	$50.0K	$53.0K	$-127.0K	$-4M	$-775.0K
Stockholders' Equity	$257M	$216M	$246M	$289M	$390M
Liabilities + Equity	$359M	$350M	$376M	$431M	$507M
Shares Outstanding	96,914,418	70,625,899	60,467,188	48,966,216	48,688,875

Nakit Akışı 13

Metrik	2025	2024	2023	2022	2021
D&A	$2M	$2M	$2M	$2M	$1M
Stock-based Comp	$19M	$30M	$27M	$30M	$22M
Restructuring	$0	$2M	$0	·	·
Operating Cash Flow	$-99M	$-65M	$-107M	$-106M	$-87M
CapEx	$607.0K	$180.0K	$2M	$5M	$1M
Investing Cash Flow	$-9M	$-51M	$158M	$58M	$-189M
Stock Issued	·	·	$58M	$0	·
Stock Repurchased	$193.0K	$194.0K	$110.0K	$0	·
Net Stock Activity	$-193.0K	$-194.0K	$58M	·	·
Financing Cash Flow	$126M	$45M	$45M	$1M	$171M
Net Change in Cash	$19M	$-71M	$97M	$-46M	$-105M
Taxes Paid	$131.0K	$76.0K	·	·	·
Free Cash Flow	$-99M	$-65M	$-109M	$-111M	$-88M

Kârlılık 7

Metrik	2025	2024	2023	2022	2021
Operating Margin	-320.5%	-336.1%	-669.8%	-416.6%	·
Net Margin	-292.1%	-296.0%	-638.3%	-412.2%	·
Pretax Margin	-291.7%	-295.6%	-632.2%	·	·
EBITDA Margin	-320.5%	-336.1%	-669.8%	-416.6%	·
ROA	-29.6%	-29.0%	-32.8%	-27.3%	-18.5%
ROE	-48.8%	-45.9%	-57.3%	-42.2%	-21.3%
ROIC	-45.0%	-55.5%	-57.0%	·	·

Likidite ve Solventlik 4

Metrik	2025	2024	2023	2022	2021
Current Ratio	7.8	5.7	6.3	6.5	6.4
Quick Ratio	2.3	1.3	3.2	0.7	6.1
Debt / Equity	·	·	0.0	0.0	0.0
LT Debt / Equity	·	·	0.0	0.0	0.0

Verimlilik 2

Metrik	Eğilim	2025	2024	2023	2022	2021
Asset Turnover		0.1	0.1	0.1	0.1	·
Receivables Turnover		13.1	4.8	3.1	8.7	·

Hisse Başına 5

Metrik	2025	2024	2023	2022	2021
Book Value / Share	$2.65	$3.06	$4.07	$5.91	$8.00
Revenue / Share	$0.43	$0.51	$0.42	$0.64	·
Cash Flow / Share	$-1.19	$-0.94	$-2.15	$-2.17	·
Cash / Share	$0.77	$0.79	$2.09	$0.61	$1.56
EPS (TTM)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82

Büyüme Oranları 2

Metrik	Eğilim	2025	2024	2023	2022	2021
Revenue YoY		1.0%	71.4%	-33.2%	-32.1%	·
Revenue CAGR 3Y		5.0%	-8.1%	·	·	·

Değerleme (TTM) 14

Metrik	2025	2024	2023	2022	2021
Revenue TTM	$36M	$36M	$21M	$31M	$46M
Net Income TTM	$-105M	$-105M	$-132M	$-128M	$-84M
Market Cap	$185M	$254M	$342M	$289M	$1.57B
Enterprise Value	·	·	$215M	$271M	$1.27B
P/E	-1.5	-2.4	-2.1	-2.3	-17.7
P/S	5.1	7.1	16.5	9.3	34.2
P/B	0.7	1.2	1.4	1.0	4.0
P / Tangible Book	0.7	1.2	1.4	1.0	4.0
P / Cash Flow	-1.9	-3.9	-3.2	-2.7	-18.0
P / FCF	-1.9	-3.9	-3.1	-2.6	-17.8
EV / EBITDA	·	·	-1.5	-2.1	-15.5
EV / FCF	·	·	-2.0	-2.4	-14.4
EV / Revenue	·	·	10.4	8.7	27.7
Earnings Yield	-66.5%	-42.2%	-47.3%	-44.4%	-5.7%

Gelir Tablosu 14

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$7M	$6M	$11M	$11M	$6M	$7M	$5M	$15M	$12M	$3M	$3M	$11M	$3M	$4M	$3M	$7M
R&D Expense	$24M	$25M	$25M	$26M	$26M	$27M	$33M	$32M	$24M	$23M	$30M	$28M	$30M	$29M	$31M	$30M
SG&A Expense	$9M	$9M	$9M	$9M	$9M	$9M	$10M	$12M	$10M	$10M	$10M	$11M	$10M	$11M	$10M	$10M
Operating Expenses	$33M	$34M	$34M	$46M	$35M	$36M	$43M	$44M	$33M	$35M	$41M	$39M	$40M	$40M	$41M	$39M
Operating Income	$-26M	$-28M	$-23M	$-34M	$-29M	$-29M	$-38M	$-28M	$-21M	$-32M	$-37M	$-28M	$-38M	$-36M	$-38M	$-32M
Other Non-op	$3M	$3M	$3M	$2M	$2M	$3M	$3M	$4M	$4M	$4M	$3M	$2M	$2M	$1M	$1M	$530.0K
Pretax Income	·	·	$-20M	$-32M	$-26M	$-26M	$-34M	$-25M	$-18M	$-28M	$-34M	$-26M	$-36M	$-35M	$-37M	$-32M
Income Tax	$0	$0	$121.0K	$0	$0	$0	$131.0K	$0	$0	$0	$277.0K	$1M	$0	$0	$0	$0
Net Income	$-24M	$-25M	$-20M	$-32M	$-26M	$-26M	$-35M	$-25M	$-18M	$-28M	$-35M	$-27M	$-36M	$-35M	$-37M	$-32M
EPS (Basic)	$-0.18	$-0.20	$-0.09	$-0.44	$-0.37	$-0.37	$-0.50	$-0.35	$-0.26	$-0.41	$-0.68	$-0.55	$-0.73	$-0.71	$-0.76	$-0.65
EPS (Diluted)	$-0.18	$-0.20	$-0.09	$-0.44	$-0.37	$-0.37	$-0.50	$-0.35	$-0.26	$-0.41	$-0.68	$-0.55	$-0.73	$-0.71	$-0.76	$-0.65
Shares (Basic)	130,696,742	126,074,555	·	72,563,311	71,005,743	70,833,044	·	69,627,190	68,810,259	68,432,168	·	49,212,126	49,063,631	49,032,319	·	48,921,928
Shares (Diluted)	130,696,742	126,074,555	·	72,563,311	71,005,743	70,833,044	·	69,627,190	68,810,259	68,432,168	·	49,212,126	49,063,631	49,032,319	·	48,921,928
EBITDA	$-26M	$-27M	·	$-34M	$-29M	$-29M	·	$-28M	$-21M	$-32M	·	$-28M	$-38M	$-36M	·	$-32M

Bilanço 22

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$79M	$61M	$75M	$59M	$78M	$51M	$55M	$60M	$73M	$90M	$127M	$61M	$45M	$49M	$30M	$50M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$264M
Receivables	$1M	$3M	$2M	$7M	$2M	$8M	$3M	$10M	$1M	$14M	$12M	$500.0K	$1M	$528.0K	$1M	$1M
Prepaid Expense	$8M	$7M	$7M	$8M	$8M	$9M	$10M	$7M	$11M	$8M	$6M	$7M	$6M	$8M	$10M	$10M
Current Assets	$263M	$245M	$258M	$207M	$225M	$233M	$258M	$273M	$276M	$280M	$271M	$224M	$274M	$278M	$288M	$325M
PP&E (Net)	$4M	$4M	$5M	$5M	$6M	$5M	$6M	$6M	$7M	$7M	$7M	$7M	$8M	$8M	$7M	$7M
PP&E (Gross)	$16M	$16M	$16M	$16M	$16M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$16M	$16M	$15M
Accum. Depreciation	$11M	$11M	$11M	$10M	$10M	$10M	$9M	$9M	$9M	$8M	$8M	$8M	$8M	$9M	$8M	$8M
Other Non-current Assets	$4M	$4M	$4M	$211.0K	$178.0K	$3M	$3M	$5M	$3M	$5M	$3M	$3M	$3M	$3M	$2M	$1M
Total Assets	$359M	$329M	$359M	$265M	$297M	$320M	$350M	$376M	$381M	$398M	$376M	$333M	$375M	$396M	$431M	$461M
Accounts Payable	$1M	$773.0K	$858.0K	$1M	$2M	$683.0K	$1M	$2M	$913.0K	$2M	$1M	$1M	$2M	$1M	$1M	$2M
Current Liabilities	$48M	$27M	$33M	$36M	$44M	$41M	$45M	$43M	$54M	$55M	$43M	$30M	$48M	$39M	$45M	$45M
Capital Leases	$50M	$52M	$54M	$55M	$57M	$58M	$60M	$61M	$63M	$64M	$66M	$67M	$68M	$70M	$71M	$72M
Total Liabilities	$112M	$95M	$102M	$111M	$122M	$124M	$134M	$133M	$134M	$140M	$130M	$117M	$141M	$134M	$142M	$143M
Long-term Debt	·	·	·	·	·	·	·	·	·	·	·	$0	$10M	$12M	$11M	$11M
Total Debt	·	·	·	·	·	·	·	·	·	·	·	·	·	$11M	·	$11M
Common Stock	$12.0K	$10.0K	$9.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$6.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K
Retained Earnings	$-787M	$-764M	$-739M	$-718M	$-686M	$-660M	$-634M	$-599M	$-574M	$-557M	$-528M	$-494M	$-467M	$-431M	$-396M	$-359M
AOCI	$-444.0K	$-322.0K	$50.0K	$87.0K	$-30.0K	$43.0K	$53.0K	$455.0K	$-440.0K	$-380.0K	$-127.0K	$-904.0K	$-2M	$-2M	$-4M	$-5M
Stockholders' Equity	$247M	$234M	$257M	$154M	$174M	$195M	$216M	$243M	$247M	$258M	$246M	$216M	$234M	$262M	$289M	$318M
Liabilities + Equity	$359M	$329M	$359M	$265M	$297M	$320M	$350M	$376M	$381M	$398M	$376M	$333M	$375M	$396M	$431M	$461M
Shares Outstanding	122,905,756	104,036,350	96,914,418	74,174,515	71,007,083	70,989,661	70,625,899	70,562,901	68,815,642	68,778,591	60,467,188	49,259,870	49,065,098	49,052,509	48,966,216	48,951,283

Nakit Akışı 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$292.0K	$404.0K	·	$460.0K	$615.0K	$456.0K	·	$442.0K	$448.0K	$448.0K	·	$447.0K	·	·	·	·
Stock-based Comp	$3M	$3M	$4M	$5M	$5M	$6M	$8M	$9M	$6M	$6M	$6M	$8M	$6M	$6M	$7M	$6M
Other Non-cash	·	$-8M	·	·	·	$-13M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-2M	$-30M	$-22M	$-31M	$-12M	$-33M	$-18M	$-24M	$-5M	$-18M	$-24M	$-31M	$-19M	$-33M	$-29M	$-28M
CapEx	$37.0K	$64.0K	$11.0K	$411.0K	$185.0K	$0	$-4.0K	$-13.0K	$197.0K	$0	$157.0K	$600.0K	$362.0K	$589.0K	$1M	$3M
Investing Cash Flow	$-15M	$16M	$-81M	$4M	$39M	$29M	$14M	$162.0K	$-12M	$-53M	$32M	$58M	$15M	$54M	$9M	$20M
Stock Repurchased	$0	$200.0K	$14.0K	$24.0K	$0	$155.0K	$0	$85.0K	$0	$109.0K	$0	$16.0K	$0	$94.0K	$0	$0
Net Stock Activity	·	$-200.0K	·	·	·	$-155.0K	·	·	·	$-109.0K	·	·	·	$-94.0K	·	·
Financing Cash Flow	$34M	$462.0K	$119M	$8M	$0	$-46.0K	$112.0K	$11M	$135.0K	$35M	$58M	$-11M	$-746.0K	$-684.0K	$47.0K	$361.0K
Net Change in Cash	$17M	$-13M	$16M	$-19M	$27M	$-4M	$-4M	$-13M	$-17M	$-37M	$66M	$16M	$-5M	$20M	$-20M	$-8M
Free Cash Flow	·	$-30M	·	·	·	·	·	·	·	$-18M	·	·	·	$-34M	·	·

Kârlılık 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-397.9%	-451.6%	·	-306.4%	-441.0%	-402.9%	·	-183.9%	-178.6%	-1060.2%	·	-251.2%	-1410.2%	-963.8%	·	-481.0%
Net Margin	-355.9%	-408.5%	·	-286.4%	-402.6%	-363.7%	·	-160.6%	-147.6%	-933.2%	·	-244.2%	-1348.4%	-925.2%	·	-473.2%
Pretax Margin	·	·	·	-286.4%	-402.6%	-363.7%	·	-160.6%	-147.6%	-933.2%	·	-235.1%	·	·	·	·
EBITDA Margin	-397.9%	-445.1%	·	-306.4%	-441.0%	-396.6%	·	-183.9%	-178.6%	-1060.2%	·	-251.2%	-1410.2%	-963.8%	·	-481.0%
ROA	-7.2%	-7.8%	·	-8.8%	-6.6%	-7.6%	·	·	·	-7.8%	·	·	·	-7.6%	·	-6.6%
ROE	-11.2%	-11.7%	·	-13.6%	-10.0%	-12.0%	·	·	·	-12.0%	·	·	·	-11.1%	·	-8.9%
ROIC	·	·	·	-22.3%	·	-14.9%	·	·	·	-12.5%	·	·	·	·	·	·

Likidite ve Solventlik 4

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	5.4	9.0	·	5.8	5.1	5.7	·	·	·	5.1	·	·	·	7.1	·	7.2
Quick Ratio	1.7	2.4	·	1.8	1.8	1.5	·	·	·	1.9	·	·	·	1.3	·	7.0
Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0	·	0.0
LT Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0	·	0.0

Verimlilik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	·	·	0.0	·	·	·	0.0	·	0.0
Receivables Turnover		3.8	1.1	·	2.8	3.3	0.8	·	·	·	0.4	·	·	·	3.3	·	2.1

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$2.01	$2.25	·	$2.08	$2.45	$2.75	·	·	·	$3.76	·	·	·	$5.35	·	$6.50
Revenue / Share	$0.05	$0.05	·	$0.15	$0.09	$0.10	·	$0.22	$0.17	$0.04	·	$0.23	$0.05	$0.08	·	$0.14
Cash Flow / Share	·	$-0.24	·	·	·	$-0.47	·	·	·	$-0.26	·	·	·	$-0.68	·	·
Cash / Share	$0.64	$0.59	·	$0.79	$1.10	$0.72	·	·	·	$1.30	·	·	·	$1.01	·	$1.01
EPS (TTM)	$-0.91	$-1.10	·	$-1.68	$-1.59	$-1.48	·	$-1.70	$-1.90	$-2.37	·	$-2.75	$-2.85	$-2.68	·	$-2.17

Değerleme (TTM) 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$35M	$35M	·	$30M	$34M	$40M	·	$34M	$29M	$20M	·	$20M	$16M	$27M	·	$48M
Net Income TTM	$-101M	$-104M	·	$-119M	$-112M	$-103M	·	$-105M	$-108M	$-126M	·	$-135M	$-140M	$-131M	·	$-107M
Market Cap	$574M	$274M	·	$165M	$102M	$114M	·	·	·	$562M	·	·	·	$154M	·	$429M
Enterprise Value	·	·	·	·	·	·	·	·	·	·	·	·	·	$115M	·	$127M
P/E	-5.1	-2.4	·	-1.3	-0.9	-1.1	·	-3.4	-2.4	-3.4	·	-0.7	-1.0	-1.2	·	-4.0
P/S	16.4	7.8	·	5.5	3.0	2.9	·	·	10.8	28.0	·	4.5	8.4	5.7	·	8.9
P/B	2.3	1.2	·	1.1	0.6	0.6	·	·	·	2.2	·	·	·	0.6	·	1.3
P / Tangible Book	2.3	1.2	·	1.1	0.6	0.6	·	·	·	2.2	·	·	·	0.6	·	1.3
P / Cash Flow	·	-9.1	·	·	·	-3.4	·	·	·	-31.0	·	·	·	-4.6	·	·
EV / Revenue	·	·	·	·	·	·	·	·	·	·	·	1.5	6.3	4.2	·	2.6
Earnings Yield	-19.5%	-41.8%	·	-75.7%	-111.2%	-92.5%	·	-29.8%	-41.1%	-29.0%	·	-147.8%	-103.6%	-85.4%	·	-24.7%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$36M	$36M	$21M	$31M	$46M
Faaliyet Kâr Marjı %	-320.5%	-336.1%	-669.8%	-416.6%	·
Net Gelir	$-105M	$-105M	$-132M	$-128M	$-84M
Seyreltilmiş Hisse Başı Kâr	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Borç / Öz Sermaye	·	·	0.0	0.0	0.0
Cari Oran	7.8	5.7	6.3	6.5	6.4
Cari Oran	2.3	1.3	3.2	0.7	6.1

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-99M	$-65M	$-109M	$-111M	$-88M

Kurumsal Sahipler (13F) 162 dosya · $544.7M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 162

Tutulan Değer $544.7M

Yeni pozisyonlar 55

Çıkan pozisyonlar 25

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
55 (+18 önceki Ç'ye göre)	25 (+16 önceki Ç'ye göre)	54 (+11 önceki Ç'ye göre)	30 (+1 önceki Ç'ye göre)	+30.8M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
MORGAN STANLEY	$41.410.468	8.867.338	7,60%	Hisse senetleri
RA CAPITAL MANAGEMENT, L.P.	$37.360.000	8.000.000	6,86%	Hisse senetleri
BlackRock, Inc.	$36.877.672	7.896.718	6,77%	Hisse senetleri
Lynx1 Capital Management LP	$34.215.647	7.326.691	6,28%	Hisse senetleri
Squadron Capital Management LLC	$33.624.000	7.200.000	6,17%	Hisse senetleri
Bain Capital Life Sciences Investors, LLC	$33.492.820	7.171.910	6,15%	Hisse senetleri
JPMORGAN CHASE & CO	$20.651.295	4.747.424	3,79%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$20.630.804	4.417.731	3,79%	Hisse senetleri
CITADEL ADVISORS LLC	$19.555.999	4.187.580	3,59%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$16.489.728	3.530.991	3,03%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$16.203.532	3.469.707	2,97%	Hisse senetleri
Soleus Capital Management, L.P.	$15.775.171	3.377.981	2,90%	Hisse senetleri
SILVERARC CAPITAL MANAGEMENT, LLC	$14.159.720	3.032.060	2,60%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$12.405.197	2.656.359	2,28%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$11.780.697	2.522.163	2,16%	Hisse senetleri
Ikarian Capital, LLC	$11.362.110	2.433.000	2,09%	Hisse senetleri
STATE STREET CORP	$9.879.950	2.115.621	1,81%	Hisse senetleri
Candriam S.C.A.	$8.383.622	1.796.937	1,54%	Hisse senetleri
VANGUARD GROUP INC	$8.365.446	4.379.815	1,54%	Hisse senetleri
D. E. Shaw & Co., Inc.	$8.130.419	1.740.989	1,49%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$8.089.421	1.732.210	1,49%	Hisse senetleri
WASATCH ADVISORS LP	$7.789.431	2.961.761	1,43%	Hisse senetleri
Patient Square Capital LP	$7.513.166	1.608.815	1,38%	Hisse senetleri
HighVista Strategies LLC	$6.295.800	1.348.136	1,16%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$5.556.497	1.189.828	1,02%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$5.546.166	1.188.507	1,02%	Hisse senetleri
NORTHERN TRUST CORP	$5.419.754	1.160.547	0,99%	Hisse senetleri
CONGRESS ASSET MANAGEMENT CO	$4.686.051	1.003.437	0,86%	Hisse senetleri
FMR LLC	$4.175.231	894.054	0,77%	Hisse senetleri
UBS Group AG	$3.871.289	828.970	0,71%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$3.647.550	781.060	0,67%	Hisse senetleri
BOOTHBAY FUND MANAGEMENT, LLC	$3.438.666	736.331	0,63%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.176.039	680.094	0,58%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$2.844.712	609.146	0,52%	Hisse senetleri
ExodusPoint Capital Management, LP	$2.709.511	580.195	0,50%	Hisse senetleri
Velan Capital Investment Management LP	$2.661.900	570.000	0,49%	Hisse senetleri
STEMPOINT CAPITAL LP	$2.445.436	523.648	0,45%	Hisse senetleri
Rockefeller Capital Management L.P.	$2.315.465	495.817	0,43%	Hisse senetleri
Nuveen, LLC	$2.260.326	484.010	0,41%	Hisse senetleri
WELLS FARGO & COMPANY/MN	$2.114.113	452.701	0,39%	Hisse senetleri
TWO SIGMA ADVISERS, LP	$2.040.262	1.068.200	0,37%	Hisse senetleri
Man Group plc	$1.908.386	408.648	0,35%	Hisse senetleri
Squadron Capital Management LLC	$1.868.000	400.000	0,34%	Alım opsiyonu
PLATINUM INVESTMENT MANAGEMENT LTD	$1.796.857	384.766	0,33%	Hisse senetleri
Seven Fleet Capital Management LP	$1.780.059	381.169	0,33%	Hisse senetleri
Qube Research & Technologies Ltd	$1.730.487	370.554	0,32%	Hisse senetleri
Atom Investors LP	$1.701.519	364.351	0,31%	Hisse senetleri
Susquehanna Portfolio Strategies, LLC	$1.564.819	335.079	0,29%	Hisse senetleri
ADAGE CAPITAL PARTNERS GP, L.L.C.	$1.517.750	325.000	0,28%	Hisse senetleri
JANE STREET GROUP, LLC	$1.413.843	302.750	0,26%	Hisse senetleri

Tüm 162 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 1 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Cobro Ventures Opportunity Fund, L.P., Cobro Opportunity Fund GP, LLC, Marc Cohen, Alain Cohen, Todd Kaloudis ×2 başvurular	15 Haziran 2021	·	İlk başvuru	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 27 içeriden öğrenenler · 13 yöneticiler · 15 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Andrew Hirsch	President & CEO	15 Şubat 2026 F	1.074.934	0	$0
Kendra Adams	Chief Financial Officer	18 Eylül 2026 F	382.323	0	$0
Lauren White	Chief Financial Officer	30 Ağustos 2023 M	32.686	0	$0
William Mckee	Chief Financial Officer	06 Ekim 2020 P	5.263	0	$0
Leonard Reyno	Chief Medical Officer	10 Temmuz 2026 F	372.406	1	$-22.200
Paige Mahaney	Chief Scientific Officer	14 Şubat 2026 F	336.910	0	$0
Mark Mossler	Chief Accounting Officer	14 Şubat 2026 F	71.916	0	$0
Scott N Boyle	Chief Business Officer	14 Şubat 2026 F	298.801	0	$0
Kelly Schick	Chief People Officer	14 Şubat 2026 F	299.881	0	$0
Jolie Siegel	Chief Legal Officer	14 Şubat 2025 A	107.939	0	$0
Stewart Fisher	Chief Scientific Officer	16 Eylül 2024 M	130.710	0	$0
Adam Crystal	Chief Medical Officer	30 Ocak 2023 M	20.097	0	$0
Laura Jean Wahlberg	VP of Finance Corp Controller	11 Şubat 2021 A	·	0	$0
Kenneth Carl Anderson	Yönetim kurulu üyesi	01 Ekim 2026 A	75.612	0	$0
Donna Roy Grogan	Yönetim kurulu üyesi	01 Ekim 2026 A	79.471	0	$0
Stephen Fawell	Yönetim kurulu üyesi	24 Haziran 2026 A	·	0	$0
Laura Bessen	Yönetim kurulu üyesi	24 Haziran 2026 A	·	0	$0
Utpal Koppikar	Yönetim kurulu üyesi	24 Haziran 2026 A	5.667	0	$0
Ronald Harold Wilfred Cooper	Yönetim kurulu üyesi	24 Haziran 2026 A	·	0	$0
Owen Hughes	Yönetim kurulu üyesi	24 Haziran 2026 A	·	0	$0
Steven L. Hoerter	Yönetim kurulu üyesi	24 Haziran 2026 A	·	0	$0
Malcolm Salter	Yönetim kurulu üyesi	20 Haziran 2024 A	11.380	0	$0
Bruce Downey	Yönetim kurulu üyesi	20 Haziran 2024 A	489.542	0	$0
Glenn Dubin	Yönetim kurulu üyesi	01 Nisan 2024 A	22.075	0	$0
Marc A Cohen	Yönetim kurulu üyesi	22 Haziran 2022 A	1.118	0	$0
Alain J Cohen	Yönetim kurulu üyesi	04 Nisan 2022 A	928	0	$0
Elena Prokupets	Yönetim kurulu üyesi	27 Eylül 2021 S	503.126	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 20 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
QQQS · Invesco Exchange-Traded Fund Trust …	0,44%	32.308 SH	02 Ekim 2026	Günlük
IWC · iShares Trust	0,08%	342.369 SH	11 Eylül 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,03%	88.122 SH	19 Ağustos 2026	Günlük
IBB · iShares Trust	0,03%	845.464 SH	11 Eylül 2026	Günlük
PRFZ · Invesco Exchange-Traded Fund Trust	0,03%	232.512 SH	02 Ekim 2026	Günlük
IBBQ · Invesco Exchange-Traded Fund Trust …	0,03%	8.690 SH	02 Ekim 2026	Günlük
IWM · iShares Trust	0,01%	2.614.567 SH	11 Eylül 2026	Günlük
RSSL · Global X Funds	0,01%	48.213 NS	31 Temmuz 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	583.446 SH	19 Ağustos 2026	Günlük
DFAS · Dimensional ETF Trust	0,01%	235.215 NS	31 Temmuz 2026	N-PORT
DXUV · Dimensional ETF Trust	0,00%	3.906 NS	31 Temmuz 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	14.611 NS	31 Temmuz 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	8.504 NS	31 Temmuz 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	115.180 NS	31 Temmuz 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	19.202 NS	31 Temmuz 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	21.036 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	1.046.993 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	3.264.924 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	8.526 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	926.223 SH	11 Eylül 2026	Günlük

CCCC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 13 analist AL

Medyan hedef $11.00 +272,9%

4 30,8% Güçlü Al

8 61,5% Al

1 7,7% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

6 analist · 2026-09-30

Ortalama hedef $13.33 +352,0%

← Tüm hedeflerin altında Mevcut fiyat $2.95

Düşük$7.00 Ortalama$13.33 Yüksek$30.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
CCCC	$185M	-1.5	1.0%	-292.1%	-48.8%	·
MYGN	$575M	-1.6	-1.6%	-44.4%	-96.8%	69.9%
RZLT	$501M	-6.9	·	·	-67.8%	·
KYTX	$568M	-2.6	·	·	-77.4%	·
SPRY	$1.16B	-6.7	-5.5%	-203.3%	-111.8%	·
EIKN	·	·	·	·	·	·
EDIT	$201M	-1.1	25.4%	-395.0%	-688.8%	·
GALT	$271M	-8.7	·	·	25.0%	·
IRD	$140M	-2.5	29.1%	-349.3%	-302.2%	·
AGEN	$111M	·	10.4%	-2.7%	1.0%	·

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

CCCC C4 Therapeutics, Inc. - Common Stock